Eric Warren
2023
In 2023, Eric Warren earned a total compensation of $1.1M as Chief Commercial Officer at Esperion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $241,259 |
|---|---|
| Option Awards | $269,200 |
| Salary | $462,500 |
| Stock Awards | $89,646 |
| Other | $15,100 |
| Total | $1,077,705 |
Warren received $462.5K in salary, accounting for 43% of the total pay in 2023.
Warren also received $241.3K in non-equity incentive plan, $269.2K in option awards, $89.6K in stock awards and $15.1K in other compensation.
Rankings
In 2023, Eric Warren's compensation ranked 1,027th out of 2,326 executives tracked by ExecPay. In other words, Warren earned more than 55.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,027 out of 2,326 | 56th |
Division Manufacturing | 606 out of 1,256 | 52nd |
Major group Chemicals And Allied Products | 408 out of 711 | 43rd |
Industry group Drugs | 398 out of 682 | 42nd |
Industry Pharmaceutical Preparations | 273 out of 493 | 45th |
Source: SEC filing on April 11, 2024.
Warren's colleagues
We found two more compensation records of executives who worked with Eric Warren at Esperion Therapeutics in 2023.